Drug Pipeline

YTS109 cell Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
4
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 1
6
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07104721 A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases Systemic Lupus Erythematosus (SLE) Recruiting
NCT07123519 A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases Systemic Lupus Erythematosus (SLE) Recruiting
NCT07236801 Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases Systemic Lupus Erythematosus (SLE) Recruiting
NCT07236762 An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases Systemic Lupus Erythematosus Recruiting
NCT07439029 YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases Systemic Lupus Erythematosus (SLE) Not Yet Recruiting
NCT07453836 Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia Autoimmune Hemolytic Anemia Not Yet Recruiting
Sponsors Running YTS109 cell Trials
Disease Areas
Get alerts when YTS109 cell trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free